GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Personalis Inc (NAS:PSNL) » Definitions » Beneish M-Score

Personalis (Personalis) Beneish M-Score : -3.41 (As of Apr. 26, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Personalis Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.41 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Personalis's Beneish M-Score or its related term are showing as below:

PSNL' s Beneish M-Score Range Over the Past 10 Years
Min: -3.41   Med: -2.41   Max: -0.64
Current: -3.41

During the past 7 years, the highest Beneish M-Score of Personalis was -0.64. The lowest was -3.41. And the median was -2.41.


Personalis Beneish M-Score Historical Data

The historical data trend for Personalis's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Personalis Beneish M-Score Chart

Personalis Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial -2.41 -1.57 -0.64 -2.88 -3.41

Personalis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.88 -2.30 -3.31 -3.36 -3.41

Competitive Comparison of Personalis's Beneish M-Score

For the Diagnostics & Research subindustry, Personalis's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Personalis's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Personalis's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Personalis's Beneish M-Score falls into.



Personalis Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Personalis for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9431+0.528 * 0.8283+0.404 * 0.8895+0.892 * 1.1297+0.115 * 0.6668
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.6881+4.679 * -0.152502-0.327 * 1.4999
=-3.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $17.73 Mil.
Revenue was 19.675 + 18.247 + 16.699 + 18.86 = $73.48 Mil.
Gross Profit was 5.205 + 3.481 + 4.792 + 4.73 = $18.21 Mil.
Total Current Assets was $146.74 Mil.
Total Assets was $225.10 Mil.
Property, Plant and Equipment(Net PPE) was $75.22 Mil.
Depreciation, Depletion and Amortization(DDA) was $11.30 Mil.
Selling, General, & Admin. Expense(SGA) was $49.73 Mil.
Total Current Liabilities was $47.23 Mil.
Long-Term Debt & Capital Lease Obligation was $38.32 Mil.
Net Income was -26.584 + -29.098 + -23.955 + -28.659 = $-108.30 Mil.
Non Operating Income was -8.115 + -5.533 + -0.151 + -3.911 = $-17.71 Mil.
Cash Flow from Operations was -13.418 + -16.681 + -10.414 + -15.745 = $-56.26 Mil.
Total Receivables was $16.64 Mil.
Revenue was 16.722 + 14.858 + 18.24 + 15.227 = $65.05 Mil.
Gross Profit was 2.312 + 2.479 + 4.281 + 4.278 = $13.35 Mil.
Total Current Assets was $199.70 Mil.
Total Assets was $292.70 Mil.
Property, Plant and Equipment(Net PPE) was $88.42 Mil.
Depreciation, Depletion and Amortization(DDA) was $8.43 Mil.
Selling, General, & Admin. Expense(SGA) was $63.97 Mil.
Total Current Liabilities was $33.13 Mil.
Long-Term Debt & Capital Lease Obligation was $41.04 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(17.73 / 73.481) / (16.642 / 65.047)
=0.241287 / 0.255846
=0.9431

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(13.35 / 65.047) / (18.208 / 73.481)
=0.205236 / 0.247792
=0.8283

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (146.744 + 75.218) / 225.099) / (1 - (199.699 + 88.415) / 292.7)
=0.013936 / 0.015668
=0.8895

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=73.481 / 65.047
=1.1297

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(8.432 / (8.432 + 88.415)) / (11.296 / (11.296 + 75.218))
=0.087065 / 0.130568
=0.6668

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(49.726 / 73.481) / (63.969 / 65.047)
=0.676719 / 0.983427
=0.6881

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((38.321 + 47.234) / 225.099) / ((41.041 + 33.131) / 292.7)
=0.380077 / 0.253406
=1.4999

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-108.296 - -17.71 - -56.258) / 225.099
=-0.152502

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Personalis has a M-score of -3.41 suggests that the company is unlikely to be a manipulator.


Personalis Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Personalis's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Personalis (Personalis) Business Description

Traded in Other Exchanges
Address
6600 Dumbarton Circle, Fremont, CA, USA, 94555
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Liquid Biopsy, NeXT Dx Test, and other Pharma Research Solutions.
Executives
Richard Chen officer: Chief Scientific Officer C/O PERSONALIS, INC., 1330 O'BRIEN DRIVE, MENLO PARK CA 94025
Stephen Michael Moore officer: General Counsel C/O PERSONALIS, INC., 1330 O'BRIEN DRIVE, MENLO PARK CA 94025
Aaron Tachibana officer: Chief Financial Officer 400 NORTH MCCARTHY BLVD, MILPITAS CA 95035
Christopher M Hall officer: President 6600 DUMBARTON CIRCLE, FREMONT CA 94555
Kenneth J Widder director 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Lonnie Shoff director C/O PERSONALIS, INC., 1330 O'BRIEN DRIVE, MENLO PARK CA 94025
John Stephen West director, officer: President and CEO C/O PERSONALIS, INC., 6600 DUMBARTON CIRCLE, FREMONT CA 94555
Lightspeed Venture Partners Select Iv, L.p. other: Affiliate of 10% Owner 2200 SAND HILL ROAD, MENLO PARK CA 94025
Olivia Kyusuk Bloom director C/O GERON CORP, 230 CONSTITUTION DRIVE, MENLO PARK CA 94025
Myers Woodrow A Jr director 1 N ILLINOIS SREET 2101, INDIANAPOLIS IN 46204
Llp Abingworth 10 percent owner 38 JERMYN STREET, LONDON X0 SW1Y 6DN
Ken Ludlum director
Arif Janmohamed other: Affiliate of 10% Owner 2200 SAND HILL ROAD, SUITE 100, MENLO PARK CA 94025
Lightspeed Ultimate General Partner Select Iv, L.l.c. other: Affiliate of 10% Owner 2200 SAND HILL ROAD, SUITE 100, MENLO PARK CA 94025
Lightspeed General Partner Select Iv, L.p. other: Affiliate of 10% Owner 2200 SAND HILL ROAD, SUITE 100, MENLO PARK CA 94025